단백질 엔지니어링 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global protein engineering market size is expected to reach USD 12.60 Billion in 2034 from USD 4.04 Billion in 2025, growing at a CAGR of 13.47% during 2026-2034.The Global Protein Engineering Market is witnessing robust growth driven by advancements in biotechnology, drug discovery, and synthetic biology. The increasing demand for targeted therapeutics, including monoclonal antibodies and enzyme-based drugs, is accelerating market expansion. Pharmaceutical and biopharmaceutical companies are investing heavily in protein modification technologies to improve efficacy, stability, and specificity of treatments. Rising research activities in genomics and proteomics further contribute to sustained market growth worldwide.

Key drivers include the growing prevalence of chronic diseases such as cancer, diabetes, and autoimmune disorders, which require highly specific biologic therapies. Technological innovations like CRISPR, computational protein design, and directed evolution are enhancing protein engineering efficiency. Additionally, increased funding from governments and private organizations for life sciences research supports market development. Expanding collaborations between academic institutions and biotech firms also strengthen innovation pipelines.

In the future, the market is expected to benefit from personalized medicine trends and advancements in artificial intelligence-driven protein modeling. Emerging applications in industrial enzymes, agriculture, and environmental biotechnology will diversify revenue streams. As biologics continue to dominate the pharmaceutical pipeline, protein engineering technologies will remain critical. The integration of automation and high-throughput screening methods is likely to further accelerate innovation and commercial adoption globally.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By End User

• Pharmaceutical And Biotechnology Companies
• Academic Research Institutes
• Contract Research Organizations

By Product

• Instruments
• Consumables
• Software

By Technology Type

• Rational or Site Directed Mutagenesis
• Irrational or Random Mutagenesis

By Protein Type

• Monoclonal Antibodies
• Insulin
• Erythropoietin
• Interferon
• Others

COMPANIES PROFILED

• Codexis, Arzeda, Ginkgo Bioworks, Twist Bioscience, Amyris, Evotec, AbCellera, Adimab, Generate Biomedicines, Absci, DeepMind/Google, Schrodinger, Insilico Medicine, Cyrus Biotechnology, ProteinQure, Tessera Therapeutics, Sola Biosciences, Sana Biotechnology, Adverum Biotechnologies, BioLoomics

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL PROTEIN ENGINEERING MARKET: BY END USER 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast End User
• 4.2. Pharmaceutical And Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Academic Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Contract Research Organizations Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PROTEIN ENGINEERING MARKET: BY PRODUCT 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Product
• 5.2. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Software Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PROTEIN ENGINEERING MARKET: BY TECHNOLOGY TYPE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Technology Type
• 6.2. Rational or Site Directed Mutagenesis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Irrational or Random Mutagenesis Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL PROTEIN ENGINEERING MARKET: BY PROTEIN TYPE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Protein Type
• 7.2. Monoclonal Antibodies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Insulin Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Erythropoietin Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Interferon Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL PROTEIN ENGINEERING MARKET: BY REGION 2022-2034 (USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By End User
  • 8.2.2 By Product
  • 8.2.3 By Technology Type
  • 8.2.4 By Protein Type
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By End User
  • 8.3.2 By Product
  • 8.3.3 By Technology Type
  • 8.3.4 By Protein Type
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Spain
  • 8.3.10 Russia
  • 8.3.11 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By End User
  • 8.4.2 By Product
  • 8.4.3 By Technology Type
  • 8.4.4 By Protein Type
  • 8.4.5 China
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 India
  • 8.4.9 Australia
  • 8.4.10 South East Asia
  • 8.4.11 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By End User
  • 8.5.2 By Product
  • 8.5.3 By Technology Type
  • 8.5.4 By Protein Type
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By End User
  • 8.6.2 By Product
  • 8.6.3 By Technology Type
  • 8.6.4 By Protein Type
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL PROTEIN ENGINEERING INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Codexis
  • 10.2.2 Arzeda
  • 10.2.3 Ginkgo Bioworks
  • 10.2.4 Twist Bioscience
  • 10.2.5 Amyris
  • 10.2.6 Evotec
  • 10.2.7 AbCellera
  • 10.2.8 Adimab
  • 10.2.9 Generate Biomedicines
  • 10.2.10 Absci
  • 10.2.11 DeepMind/Google
  • 10.2.12 Schrodinger
  • 10.2.13 Insilico Medicine
  • 10.2.14 Cyrus Biotechnology
  • 10.2.15 ProteinQure
  • 10.2.16 Tessera Therapeutics
  • 10.2.17 Sola Biosciences
  • 10.2.18 Sana Biotechnology
  • 10.2.19 Adverum Biotechnologies
  • 10.2.20 BioLoomics